Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
5.20
-0.03 (-0.57%)
Jan 21, 2026, 11:43 AM HKT
39.78% (1Y)
| Market Cap | 18.33B |
| Revenue (ttm) | 5.88B |
| Net Income (ttm) | 459.25M |
| Shares Out | n/a |
| EPS (ttm) | 0.31 |
| PE Ratio | 39.90 |
| Forward PE | n/a |
| Dividend | 0.27 (5.19%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 336,000 |
| Average Volume | 790,398 |
| Open | 5.20 |
| Previous Close | 5.23 |
| Day's Range | 5.18 - 5.25 |
| 52-Week Range | 3.60 - 7.26 |
| Beta | 0.50 |
| RSI | 45.27 |
| Earnings Date | Mar 31, 2026 |